These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28722360)

  • 1. [Not Available].
    Harr T; Spertini F; Seebach J
    Rev Med Suisse; 2017 Apr; 13(557):731-732. PubMed ID: 28722360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyposensitization].
    Przybilla B; Ring J
    Internist (Berl); 1991 Oct; 32(10):606-11. PubMed ID: 1761393
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosing intervals in intralymphatic immunotherapy.
    Hjálmsdóttir Á; Wäckerle-Men Y; Duda A; Kündig TM; Johansen P
    Clin Exp Allergy; 2016 Mar; 46(3):504-7. PubMed ID: 26470052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyposensitization in general practice. A strategic concept].
    Jorde W
    HNO; 1995 Dec; 43(12):741-4. PubMed ID: 8582837
    [No Abstract]   [Full Text] [Related]  

  • 5. Dendritic cells in allergen-specific immunotherapy.
    Novak N
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():91-2. PubMed ID: 19221629
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy with allergens.
    Creticos PS; Norman PS
    JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669
    [No Abstract]   [Full Text] [Related]  

  • 7. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 8. Different methods of local allergen-specific immunotherapy.
    Kägi MK; Wüthrich B
    Allergy; 2002 May; 57(5):379-88. PubMed ID: 11972476
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral allergen immunotherapy by targeting Peyer's patches.
    Roth-Walter F
    Allergy; 2019 Aug; 74(8):1594-1597. PubMed ID: 31006121
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergen-specific immunotherapy: current concepts and future directions.
    Bieber T; Simon HU
    Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
    Malling HJ
    Ugeskr Laeger; 1989 Nov; 151(48):3249-52. PubMed ID: 2595857
    [No Abstract]   [Full Text] [Related]  

  • 12. Apple desensitization in two patients with PR-10 proteins allergy.
    Nucera E; Aruanno A; Lombardo C; Patriarca G; Schiavino D
    Allergy; 2010 Aug; 65(8):1060-1. PubMed ID: 19958318
    [No Abstract]   [Full Text] [Related]  

  • 13. Historical perspectives of allergy and immunology and allergen immunotherapy.
    Lockey RF
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):587-92. PubMed ID: 25454016
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary!
    Lombardi C
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):530-1. PubMed ID: 25863450
    [No Abstract]   [Full Text] [Related]  

  • 16. LAIS - Posological schedules.
    Bruno M
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specific immunotherapy in allergies--evaluation of current status].
    Jarisch R; Hemmer W
    Wien Med Wochenschr; 1996; 146(15):422-5. PubMed ID: 9012204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for systemic reactions to allergen-specific subcutaneous immunotherapy.
    Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Pérez-Pimiento A; Vargas Núñez JA; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(7):621-2. PubMed ID: 21314007
    [No Abstract]   [Full Text] [Related]  

  • 19. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergen vaccines for specific diagnosis.
    Larsen JN; Løwenstein H
    Clin Allergy Immunol; 2000; 15():1-51. PubMed ID: 10943287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.